Compare RGEN & SUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGEN | SUZ |
|---|---|---|
| Founded | 1981 | 1924 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 10.8B |
| IPO Year | 1995 | 2002 |
| Metric | RGEN | SUZ |
|---|---|---|
| Price | $178.78 | $8.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 22 | 6 |
| Target Price | ★ $197.95 | $12.55 |
| AVG Volume (30 Days) | 1.2M | ★ 2.4M |
| Earning Date | 10-27-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 2.25% |
| EPS Growth | ★ 286.96 | N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $141,236,000.00 | N/A |
| Revenue This Year | $12.87 | $8.34 |
| Revenue Next Year | $29.67 | $14.27 |
| P/E Ratio | $743.42 | ★ $5.58 |
| Revenue Growth | ★ 35.10 | N/A |
| 52 Week Low | $100.99 | $7.56 |
| 52 Week High | $198.87 | $11.54 |
| Indicator | RGEN | SUZ |
|---|---|---|
| Relative Strength Index (RSI) | 51.87 | 44.51 |
| Support Level | $159.22 | $8.17 |
| Resistance Level | $188.73 | $8.67 |
| Average True Range (ATR) | 8.81 | 0.17 |
| MACD | -1.51 | -0.01 |
| Stochastic Oscillator | 52.38 | 48.66 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.